Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Yap

Showing results (81-90 of 260) with videos related to

Pageof 26
Sort By:
Current Drug Targets|July 23, 2011
HGF/c-MET targeted therapeutics: novel strategies for cancer medicineTimothy A Yap, Shahneen K Sandhu, Salma M Alam, et al.
NPJ Precision Oncology|January 11, 2023
Antibody-drug conjugates in lung cancer: dawn of a new era?Niamh Coleman, Timothy A Yap, John V Heymach, et al.
CA: a Cancer Journal for Clinicians|January 6, 2011
Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinicTimothy A Yap, Shahneen K Sandhu, Craig P Carden, et al.
Cancer Discovery|November 3, 2025
Germline Mutations as Cancer Drug TargetsTin-Yun Tang, Karen Colbert Maresso, Joanne Ngeow, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2016
Development of molecularly targeted agents and immunotherapies in small cell lung cancerAdam Sharp, Jaishree Bhosle, Fatma Abdelraouf, et al.
Drugs|April 6, 2017
Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung CancerSaoirse O Dolly, Dearbhaile C Collins, Raghav Sundar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2014
Circulating tumor cells: a multifunctional biomarkerTimothy A Yap, David Lorente, Aurelius Omlin, et al.
Trends in Cancer|July 3, 2021
Targeting the replication stress response through synthetic lethal strategies in cancer medicineNatalie Y L Ngoi, Melissa M Pham, David S P Tan, et al.
Cell|April 17, 2026
Targeting genomic instability in cancerTimothy A Yap, H Charles Manning, Puja Sapra, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 18, 2025
Baseline PARP-1 PET imaging in patients with advanced solid tumors with DNA damage response mutationsTarek Daoud, Jiansong Chen, Peng Wei, et al.
Pageof 26

Showing results (81-90 of 260) with videos related to

Sort By:
Pageof 26
Current Drug Targets|July 23, 2011
HGF/c-MET targeted therapeutics: novel strategies for cancer medicineTimothy A Yap, Shahneen K Sandhu, Salma M Alam, et al.
NPJ Precision Oncology|January 11, 2023
Antibody-drug conjugates in lung cancer: dawn of a new era?Niamh Coleman, Timothy A Yap, John V Heymach, et al.
CA: a Cancer Journal for Clinicians|January 6, 2011
Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinicTimothy A Yap, Shahneen K Sandhu, Craig P Carden, et al.
Cancer Discovery|November 3, 2025
Germline Mutations as Cancer Drug TargetsTin-Yun Tang, Karen Colbert Maresso, Joanne Ngeow, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2016
Development of molecularly targeted agents and immunotherapies in small cell lung cancerAdam Sharp, Jaishree Bhosle, Fatma Abdelraouf, et al.
Drugs|April 6, 2017
Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung CancerSaoirse O Dolly, Dearbhaile C Collins, Raghav Sundar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2014
Circulating tumor cells: a multifunctional biomarkerTimothy A Yap, David Lorente, Aurelius Omlin, et al.
Trends in Cancer|July 3, 2021
Targeting the replication stress response through synthetic lethal strategies in cancer medicineNatalie Y L Ngoi, Melissa M Pham, David S P Tan, et al.
Cell|April 17, 2026
Targeting genomic instability in cancerTimothy A Yap, H Charles Manning, Puja Sapra, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 18, 2025
Baseline PARP-1 PET imaging in patients with advanced solid tumors with DNA damage response mutationsTarek Daoud, Jiansong Chen, Peng Wei, et al.
Pageof 26